Funded Tech Companies
VaxInnate
Researching who provided funding to VaxInnate? Private investors, HealthCare Ventures and MedImmune Ventures joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
VaxInnate
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
3 Cedar Brook Dr. 1
Cranbury, NJ 08512
USA
Cranbury, NJ 08512
USA
Phone
Website
Email Address
Company Background Information
Overview
VaxInnate is a privately-held biotechnology company developing novel, proprietary vaccines for both pandemic and seasonal influenza. The company's breakthrough vaccines are based on its Toll-like receptor (TLR) technology platform, which dramatically improves vaccine immunogenicity and efficacy.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/29/2015
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Wayne Pisano
Chief Financial Officer
Kathleen McGowan
Chief Scientific Officer
Lynda Tussey
VP - Manufacturing
Bruce Weaver
Company Investors
- HealthCare Ventures (Augustine Lawlor)
- MedImmune Ventures
- New Leaf Venture Partners (Philippe Chambon)
- Canaan Partners (Seth Rudnick)
- CHL Medical Partners (Gregory Weinhoff)
- Oxford Bioscience Partners (Ellen Baron)
- The Wellcome Trust (Julie Eskay-Eagle)
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs